ArticlePloS one2014
Phase I clinical trial of fibronectin CH296-stimulated T cell therapy in patients with advanced cancer.
Takeshi Ishikawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticlePloS one2014
Takeshi Ishikawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.